282 related articles for article (PubMed ID: 16140776)
1. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
Rush M; Zhao X; Schwartz S
J Virol; 2005 Sep; 79(18):12002-15. PubMed ID: 16140776
[TBL] [Abstract][Full Text] [Related]
2. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
Zhao X; Rush M; Schwartz S
J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
[TBL] [Abstract][Full Text] [Related]
3. A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.
Zhao X; Oberg D; Rush M; Fay J; Lambkin H; Schwartz S
J Virol; 2005 Apr; 79(7):4270-88. PubMed ID: 15767428
[TBL] [Abstract][Full Text] [Related]
4. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers.
Zhao X; Fay J; Lambkin H; Schwartz S
Virology; 2007 Dec; 369(2):351-63. PubMed ID: 17869320
[TBL] [Abstract][Full Text] [Related]
5. A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.
Oberg D; Fay J; Lambkin H; Schwartz S
J Virol; 2005 Jul; 79(14):9254-69. PubMed ID: 15994820
[TBL] [Abstract][Full Text] [Related]
6. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
[TBL] [Abstract][Full Text] [Related]
7. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
8. Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.
Somberg M; Schwartz S
J Virol; 2010 Aug; 84(16):8219-30. PubMed ID: 20519389
[TBL] [Abstract][Full Text] [Related]
9. HPV-16 RNA processing.
Schwartz S
Front Biosci; 2008 May; 13():5880-91. PubMed ID: 18508629
[TBL] [Abstract][Full Text] [Related]
10. Papillomavirus transcripts and posttranscriptional regulation.
Schwartz S
Virology; 2013 Oct; 445(1-2):187-96. PubMed ID: 23706315
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction.
Rotenberg MO; Chow LT; Broker TR
Virology; 1989 Oct; 172(2):489-97. PubMed ID: 2552659
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
Kyo S; Tam A; Laimins LA
Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
[TBL] [Abstract][Full Text] [Related]
13. Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor.
Zheng ZM; He P; Baker CC
J Virol; 1996 Jul; 70(7):4691-9. PubMed ID: 8676495
[TBL] [Abstract][Full Text] [Related]
14. A novel splice donor site at nt 1534 is required for long-term maintenance of HPV31 genomes.
Poppelreuther S; Iftner T; Stubenrauch F
Virology; 2008 Jan; 370(1):93-101. PubMed ID: 17904182
[TBL] [Abstract][Full Text] [Related]
15. Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.
Li X; Johansson C; Glahder J; Mossberg AK; Schwartz S
Nucleic Acids Res; 2013 Dec; 41(22):10488-508. PubMed ID: 24013563
[TBL] [Abstract][Full Text] [Related]
16. The HIV-1 major splice donor D1 is activated by splicing enhancer elements within the leader region and the p17-inhibitory sequence.
Asang C; Erkelenz S; Schaal H
Virology; 2012 Oct; 432(1):133-45. PubMed ID: 22749061
[TBL] [Abstract][Full Text] [Related]
17. Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo.
Zheng ZM; Quintero J; Reid ES; Gocke C; Baker CC
J Virol; 2000 Jul; 74(13):5902-10. PubMed ID: 10846071
[TBL] [Abstract][Full Text] [Related]
18. A cell-type-specific transcription enhancer of type 16 human papillomavirus (HPV 16)-P97 promoter is defined with HPV-associated cellular events in human epithelial cell lines.
Taniguchi A; Kikuchi K; Nagata K; Yasumoto S
Virology; 1993 Aug; 195(2):500-10. PubMed ID: 8393236
[TBL] [Abstract][Full Text] [Related]
19. Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.
Zheng ZM; Reid ES; Baker CC
J Virol; 2000 Nov; 74(22):10612-22. PubMed ID: 11044105
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
